HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

Summary

This individual patient expanded access IND is requested for a patient diagnosed with LMNA-related congenital muscular dystrophy (L-CMD). In this expanded access, the patient will receive the investigational product through 14 intravenous infusions, followed by Follow-Up visit and an End of Study.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications